Journal of Medical Economics
Volume 27, 2024 - Issue 1
Open access
1,142
Views
0
CrossRef citations to date
0
Altmetric
Oncology
Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation
Deborah R. Kayea Duke University Cancer Center, Durham, NC, USA
, Ibrahim Khilfehb Janssen Scientific Affairs, LLC., Horsham, PA, USA
, Erik Muserb Janssen Scientific Affairs, LLC., Horsham, PA, USA
, Laura Morrisonc Analysis Group, Inc., Montréal, QC, Canada
, Frederic Kinkeadc Analysis Group, Inc., Montréal, QC, Canada
, Ana Urosevicc Analysis Group, Inc., Montréal, QC, Canada
, Patrick Lefebvrec Analysis Group, Inc., Montréal, QC, Canada
, Dominic Pilonc Analysis Group, Inc., Montréal, QC, CanadaCorrespondence[email protected]
& Daniel J. Georgea Duke University Cancer Center, Durham, NC, USA
show all
Pages 201-214
|
Received 28 Aug 2023, Accepted 08 Jan 2024, Published online: 02 Feb 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.